lung-cancer

Documents about lung-cancer

• A multiomic framework for predicting laryngo-esophageal dysfunction following induction chemotherapy in hypopharyngeal-laryngeal carcinoma#411571Dipòsit Digital de la Universitat de Barcelona
• Survival in Men Treated for Lung Cancer: A Single-Center Retrospective Cohort Study in Poland.#12959NCBI PubMed Central
• Impact of Dysbiosis-inducing Drugs on Effectivity of Immune Checkpoint Inhibitor in Non-small Cell Lung Cancer Patients#28340ClinicalTrials.gov
• Hypofractionated Versus Conventional Chemoradiotherapy Followed by Consolidative Immunotherapy in Locally Advanced NSCLC#67888ClinicalTrials.gov
• Sugemalimab as Consolidation Therapy in Patients With LS-SCLC Following cCRT or sCRT#123480ClinicalTrials.gov
• Reducing Stigma in Lung Cancer Screening: Co-Design of a Targeted Resource for Health Professionals in Australia.#140487NCBI PubMed Central
• Smoking cessation services and shared decision-making practices among lung cancer screening facilities: A cross-sectional study.#154464NCBI PubMed Central
• Treatment and Biomarker Testing Patterns,Treatment Outcomes in a/m NSCLC With and Without Actionable Genomic Alterations#154671ClinicalTrials.gov
• Understanding LUng Cancer risk factors and their Impact Assessment (LUCIA): protocol for multicentre observational cohort study.#156955NCBI PubMed Central
• Understanding Public Perceptions of Lung Cancer in China: Infodemiology Study of Baidu Index and Weibo Posts.#157903NCBI PubMed Central
• A Phase 1 Study Evaluating the Safety, Tolerability and Efficacy of AMG 119 in Subjects With RR SCLC#172302ClinicalTrials.gov
• A Roadmap to Transform Lung Cancer Outcomes: Priorities in Biology, Therapeutic Innovation, Early Detection, Prevention and Interception#211670PMC Full-Text (OAI)
• OSE2101 Versus Chemotherapy in HLA-A2 Positive Patients With Advanced NSCLC After Immune Checkpoint Inhibitor Failure#226273ClinicalTrials.gov
• Staggered, Chemo-Immunotherapy With Durvalumab, MEDI4736 Pemetrexed & Carboplatin (PC) for Metastatic Non-Squamous NSCLC#252985ClinicalTrials.gov
• A Randomized Study of Primary Tumor Radiotherapy for Patients With Stage Ⅳ NSCLC#261512ClinicalTrials.gov
• A fusion-based multiomics classification approach for enhanced gene discovery in non-small cell lung cancer.#266986NCBI PubMed Central
• Synthesis of novel artesunate derivatives and their in vitro activity against non-small cell lung cancer cells#274423IBISS
• Feasibility and acceptability of ExerciseGuideUK for those living with and beyond lung cancer: a mixed methods study.#275358NCBI PubMed Central
• A rationale for surgical debulking to improve anti-PD1 therapy outcome in non small cell lung cancer#308334HAL (France)
• Potential Immune Microenvironment Biomarkers in SCLC: J-TAIL-2 Observational Study#309400OKAYAMA UNIVERSITY SCIENTIFIC ACHIEVEMENT REPOSITORY
• Decision-Making Readiness and Its Influencing Factors Among Lung Cancer Patients Receiving Chemotherapy: A Cross-Sectional Study.#322806NCBI PubMed Central
• Association between Advanced Lung Cancer Inflammation Index and mortality in US adults with obstructive sleep apnea.#322931NCBI PubMed Central
• Established and Emerging Less Invasive Biomarkers and Technologies for Lung Cancer Screening: Puerto Rican Context.#334698NCBI PubMed Central
• Non-Pharmacological Interventions for Cough in Patients With Lung Cancer: A Systematic Review and Meta-Analysis.#360476NCBI PubMed Central
• Safety, Efficacy and Pharmacokinetics of ALD518 in Patients With Non-Small Cell Lung Cancer-related Fatigue and Cachexia#363598ClinicalTrials.gov
• ICI Rechallenge for Advanced NSCLC With Long-Term Response to First-Line ICI#377427ClinicalTrials.gov
• Evaluating Large Reasoning Models Versus Human Multidisciplinary Teams in Lung Cancer Decision-Making: Real-World Study.#378552NCBI PubMed Central
• Chitosan loaded plant essential oils efficiently eradicate the multi-drug resistant bacterial infection and lung cancer cells#400834Repositorio Académico de la Universidad de Chile
• Supplemental Material for: Taxane-Induced Interstitial Lung Disease (Pneumonitis) in Breast Cancer: A Case Series#436119Figshare
• Mycoplasma infection drives EGFR-TKI resistance through convergent transcriptomic reprogramming in non-small cell lung cancer.#442884NCBI PubMed Central
• Study of DECOY20 With or Without Tislelizumab in Patients With Advanced Solid Tumors#332761ClinicalTrials.gov
• Sexual dimorphism in exposure to particulate matter (PM2.5) and residential radon (Rn), and its association with incidence rates of TB and lung cancer (CaP) in the 43 districts of Metropolitan Lima#197316Repositorio Institucional de la PUCP
• Real-World Effectiveness of Afatinib (Gilotrif) Following Immunotherapy in the Treatment of Metastatic, Squamous Cell Carcinoma of the Lung: A Multi-Site Retrospective Chart Review Study in the U.S.#249611ClinicalTrials.gov
• Quality and Reliability of Lung Cancer Treatment Short Videos on Chinese Social Media: A Cross-Sectional Analysis for Cancer Education Improvement (January 1, 2020-October 30, 2025).#28241NCBI PubMed Central
• Assessment of Adebelizumab Combined with Chemotherapy in Concurrent Radiotherapy Versus Sequential Radiotherapy As First-Line Treatment for Extensive-Stage Small Cell Lung Cancer#162477ClinicalTrials.gov
• KO-2806 Monotherapy and Combination Therapies in Advanced Solid Tumors#158233ClinicalTrials.gov
• A Study in the United States Using Electronic Medical Records (EMR) to Assess Effectiveness of Afatinib (Gilotrif) Following Pembrolizumab and Chemotherapy in the Treatment of Metastatic Squamous Cell Carcinoma of the Lung#18581ClinicalTrials.gov
• A Phase I/Ib Study of NZV930 Alone and in Combination With PDR001 and /or NIR178 in Patients With Advanced Malignancies.#373613ClinicalTrials.gov
• Enhancing lung cancer screening through 'saved by the scan': insights from a multipronged public service advertising campaign.#9308NCBI PubMed Central
• Dual-Target CAR-NK Cells Directed Against MSLN, EGFR, or HER2 in Advanced NSCLC#127600ClinicalTrials.gov
• Safety, Tolerability, Pharmacokinetics & Pharmacodynamics of an Anti-PD-1 mAb for Patients With Advanced Solid Tumors#127604ClinicalTrials.gov
• SLC16A7 and WDR38 form a mitochondrial-centric axis driving lung cancer through metabolic reprogramming and REDOX adaptation.#135800NCBI PubMed Central
• Cardiovascular Adverse Events After Definitive Chemoradiotherapy for Lung Cancer in an Appalachian Population: Incidence and Machine Learning Based Prediction#150410bioRxiv / medRxiv
• Patients with high distressed communities index score are at risk for "no-show" to lung cancer screening appointments.#152276NCBI PubMed Central
• Self‐Assembled Peptide‐Gold Nanoclusters with SiRNA Targeting Telomeric Response to Enhance Radiosensitivity in Lung Cancer Cells#157672HAL (France)
• Radon and lung cancer in the pooled uranium miners analysis (PUMA): highly exposed early miners and all miners#161203HAL (France)
• NeoTRACK - Dissection of IO Efficacy in NSCLC by Longitudinal tracKing#184832ClinicalTrials.gov
• The lung cancer-associated blood biomarker hPG80 exhibits a reversible increase in response to smoking in asymptomatic individuals#218141HAL (France)
• AI-based chest X-ray prioritization in the lung cancer diagnostic pathway: the LungIMPACT randomized controlled trial.#219097NCBI PubMed Central
• Sputum Liquid Biopsy for Lung Cancer Screening, Diagnosis, Subtyping, Surveillance, Response Prediction, and Prognostication: A Scoping Review.#236034NCBI PubMed Central